ADRB3 and familial dilated cardiomyopathy: We tested whether the overexpression of the β3-AR could protect from developing β1-aabs-induced DCM by applying the protocol of immunization previously described to 12 transgenic (heterozygous) mice overexpressing the β3-AR (TG) and 12 wild-type littermates (WT).